

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.99801622 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 5.42809567 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 5.42809567 |
| 4 | tricarboxylic acid cycle (GO:0006099) | 5.10521572 |
| 5 | drug transmembrane transport (GO:0006855) | 4.69383949 |
| 6 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.65451285 |
| 7 | protein retention in ER lumen (GO:0006621) | 4.61001169 |
| 8 | NADH metabolic process (GO:0006734) | 4.44961176 |
| 9 | lysine metabolic process (GO:0006553) | 4.39901601 |
| 10 | lysine catabolic process (GO:0006554) | 4.39901601 |
| 11 | protein maturation by protein folding (GO:0022417) | 4.38784503 |
| 12 | organic cation transport (GO:0015695) | 4.23529467 |
| 13 | urate metabolic process (GO:0046415) | 4.22432718 |
| 14 | drug transport (GO:0015893) | 4.17900469 |
| 15 | * glycoside metabolic process (GO:0016137) | 4.14828842 |
| 16 | tricarboxylic acid metabolic process (GO:0072350) | 4.08221296 |
| 17 | L-phenylalanine metabolic process (GO:0006558) | 4.00300967 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.00300967 |
| 19 | toxin transport (GO:1901998) | 3.88752313 |
| 20 | relaxation of cardiac muscle (GO:0055119) | 3.85885580 |
| 21 | peptide catabolic process (GO:0043171) | 3.82588815 |
| 22 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.73404222 |
| 23 | quaternary ammonium group transport (GO:0015697) | 3.71500126 |
| 24 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.66761314 |
| 25 | phosphate ion transport (GO:0006817) | 3.65035326 |
| 26 | cell adhesion mediated by integrin (GO:0033627) | 3.63545189 |
| 27 | succinate metabolic process (GO:0006105) | 3.63474413 |
| 28 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.63192476 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.61317254 |
| 30 | protein carboxylation (GO:0018214) | 3.61317254 |
| 31 | valine metabolic process (GO:0006573) | 3.58211620 |
| 32 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.49361178 |
| 33 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.48857162 |
| 34 | glycosphingolipid catabolic process (GO:0046479) | 3.38455519 |
| 35 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.36767250 |
| 36 | branched-chain amino acid metabolic process (GO:0009081) | 3.33796146 |
| 37 | oxaloacetate metabolic process (GO:0006107) | 3.32000072 |
| 38 | negative regulation of fibrinolysis (GO:0051918) | 3.31159598 |
| 39 | 2-oxoglutarate metabolic process (GO:0006103) | 3.30042009 |
| 40 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.29758585 |
| 41 | pinocytosis (GO:0006907) | 3.28592389 |
| 42 | oligosaccharide catabolic process (GO:0009313) | 3.27899470 |
| 43 | renal absorption (GO:0070293) | 3.23497602 |
| 44 | fibrinolysis (GO:0042730) | 3.21129492 |
| 45 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.20335792 |
| 46 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.20335792 |
| 47 | sarcomere organization (GO:0045214) | 3.20044419 |
| 48 | proline biosynthetic process (GO:0006561) | 3.19352891 |
| 49 | hyaluronan catabolic process (GO:0030214) | 3.19302479 |
| 50 | phagosome maturation (GO:0090382) | 3.18604001 |
| 51 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.17732925 |
| 52 | regulation of relaxation of muscle (GO:1901077) | 3.17477687 |
| 53 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.17004771 |
| 54 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.16810952 |
| 55 | respiratory electron transport chain (GO:0022904) | 3.16035959 |
| 56 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.15165735 |
| 57 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.14647375 |
| 58 | L-phenylalanine catabolic process (GO:0006559) | 3.14647375 |
| 59 | regulation of actin filament-based movement (GO:1903115) | 3.13946694 |
| 60 | amino-acid betaine transport (GO:0015838) | 3.13783605 |
| 61 | carnitine transport (GO:0015879) | 3.13783605 |
| 62 | aspartate family amino acid catabolic process (GO:0009068) | 3.13645141 |
| 63 | regulation of fibrinolysis (GO:0051917) | 3.13217131 |
| 64 | glycolipid catabolic process (GO:0019377) | 3.12521004 |
| 65 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.12284744 |
| 66 | phosphate ion transmembrane transport (GO:0035435) | 3.12248366 |
| 67 | fatty acid beta-oxidation (GO:0006635) | 3.10798880 |
| 68 | electron transport chain (GO:0022900) | 3.09567120 |
| 69 | angiotensin maturation (GO:0002003) | 3.09161024 |
| 70 | COPII vesicle coating (GO:0048208) | 3.06556046 |
| 71 | short-chain fatty acid metabolic process (GO:0046459) | 3.06372905 |
| 72 | heart contraction (GO:0060047) | 3.02339536 |
| 73 | heart process (GO:0003015) | 3.02339536 |
| 74 | skin morphogenesis (GO:0043589) | 3.01659078 |
| 75 | regulation of metalloenzyme activity (GO:0048552) | 3.00382710 |
| 76 | 4-hydroxyproline metabolic process (GO:0019471) | 2.99561781 |
| 77 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.99094619 |
| 78 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.98277697 |
| 79 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.97734028 |
| 80 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.97734028 |
| 81 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.97734028 |
| 82 | modulation by symbiont of host immune response (GO:0052553) | 2.97734028 |
| 83 | positive regulation by symbiont of host defense response (GO:0052509) | 2.97734028 |
| 84 | modulation by symbiont of host defense response (GO:0052031) | 2.97734028 |
| 85 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.96736539 |
| 86 | excretion (GO:0007588) | 2.96674804 |
| 87 | surfactant homeostasis (GO:0043129) | 2.95105702 |
| 88 | response to thyroid hormone (GO:0097066) | 2.93483747 |
| 89 | regulation of cholesterol esterification (GO:0010872) | 2.93177028 |
| 90 | branched-chain amino acid catabolic process (GO:0009083) | 2.92610022 |
| 91 | plasma lipoprotein particle assembly (GO:0034377) | 2.91568304 |
| 92 | regulation of protein activation cascade (GO:2000257) | 2.90041811 |
| 93 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.88659437 |
| 94 | apoptotic cell clearance (GO:0043277) | 2.88226530 |
| 95 | cytidine deamination (GO:0009972) | 2.87046072 |
| 96 | cytidine metabolic process (GO:0046087) | 2.87046072 |
| 97 | cytidine catabolic process (GO:0006216) | 2.87046072 |
| 98 | basement membrane organization (GO:0071711) | 2.86713281 |
| 99 | regulation of complement activation (GO:0030449) | 2.83873764 |
| 100 | ATP synthesis coupled proton transport (GO:0015986) | 2.82427495 |
| 101 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.82427495 |
| 102 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.81059809 |
| 103 | NADPH regeneration (GO:0006740) | 2.80265393 |
| 104 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.79980806 |
| 105 | regulation of coenzyme metabolic process (GO:0051196) | 2.78168966 |
| 106 | regulation of cofactor metabolic process (GO:0051193) | 2.78168966 |
| 107 | carnitine metabolic process (GO:0009437) | 2.78098228 |
| 108 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.77247267 |
| 109 | ribosome assembly (GO:0042255) | 2.75659413 |
| 110 | peptidyl-proline hydroxylation (GO:0019511) | 2.74394357 |
| 111 | daunorubicin metabolic process (GO:0044597) | 2.73870617 |
| 112 | polyketide metabolic process (GO:0030638) | 2.73870617 |
| 113 | doxorubicin metabolic process (GO:0044598) | 2.73870617 |
| 114 | glutathione biosynthetic process (GO:0006750) | 2.73809245 |
| 115 | negative regulation of protein activation cascade (GO:2000258) | 2.73486604 |
| 116 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.73464513 |
| 117 | proteasome assembly (GO:0043248) | 2.73178076 |
| 118 | protein hydroxylation (GO:0018126) | 2.72854176 |
| 119 | protein-lipid complex assembly (GO:0065005) | 2.72454088 |
| 120 | cardiac muscle contraction (GO:0060048) | 2.71674497 |
| 121 | pentose-phosphate shunt (GO:0006098) | 2.71520446 |
| 122 | oxidative phosphorylation (GO:0006119) | 2.71513436 |
| 123 | neutrophil activation involved in immune response (GO:0002283) | 2.70830393 |
| 124 | ceramide catabolic process (GO:0046514) | 2.68595292 |
| 125 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.68528748 |
| 126 | lipid oxidation (GO:0034440) | 2.67027819 |
| 127 | keratan sulfate catabolic process (GO:0042340) | 2.66944352 |
| 128 | fatty acid oxidation (GO:0019395) | 2.66481823 |
| 129 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.65446300 |
| 130 | sphingolipid catabolic process (GO:0030149) | 2.65143947 |
| 131 | transferrin transport (GO:0033572) | 2.64396523 |
| 132 | regulation of cell communication by electrical coupling (GO:0010649) | 2.63901337 |
| 133 | glucose 6-phosphate metabolic process (GO:0051156) | 2.63515263 |
| 134 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.63087329 |
| 135 | membrane lipid catabolic process (GO:0046466) | 2.61992106 |
| 136 | peptidyl-asparagine modification (GO:0018196) | 2.60518884 |
| 137 | response to mercury ion (GO:0046689) | 2.60414472 |
| 138 | cardiac myofibril assembly (GO:0055003) | 2.59680485 |
| 139 | cholesterol efflux (GO:0033344) | 2.59490659 |
| 140 | hydrogen ion transmembrane transport (GO:1902600) | 2.59379286 |
| 141 | regulation of plasminogen activation (GO:0010755) | 2.59355017 |
| 142 | histamine transport (GO:0051608) | 2.58148955 |
| 143 | respiratory burst (GO:0045730) | 2.57715509 |
| 144 | cell communication involved in cardiac conduction (GO:0086065) | 2.57095168 |
| 145 | low-density lipoprotein particle clearance (GO:0034383) | 2.56670993 |
| 146 | fatty acid catabolic process (GO:0009062) | 2.56547750 |
| 147 | negative regulation of complement activation (GO:0045916) | 2.56008576 |
| 148 | protein localization to endosome (GO:0036010) | 2.55763016 |
| 149 | response to host immune response (GO:0052572) | 2.55509765 |
| 150 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.55509765 |
| 151 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.54835135 |
| 152 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.54818061 |
| 153 | macrophage activation involved in immune response (GO:0002281) | 2.54725317 |
| 154 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.53011779 |
| 155 | establishment of integrated proviral latency (GO:0075713) | 2.52694157 |
| 156 | hydrogen peroxide catabolic process (GO:0042744) | 2.52297580 |
| 157 | cellular response to zinc ion (GO:0071294) | 2.51380838 |
| 158 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.50291074 |
| 159 | protein N-linked glycosylation (GO:0006487) | 2.50020805 |
| 160 | barbed-end actin filament capping (GO:0051016) | 2.47295559 |
| 161 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.46556264 |
| 162 | ferric iron transport (GO:0015682) | 2.46548582 |
| 163 | trivalent inorganic cation transport (GO:0072512) | 2.46548582 |
| 164 | metanephric nephron tubule development (GO:0072234) | 2.46382185 |
| 165 | glucose catabolic process (GO:0006007) | 2.45912864 |
| 166 | vesicle coating (GO:0006901) | 2.43634432 |
| 167 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.43426844 |
| 168 | regulation of translational termination (GO:0006449) | 2.42984860 |
| 169 | plasma lipoprotein particle clearance (GO:0034381) | 2.42331829 |
| 170 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.42268177 |
| 171 | negative regulation of coagulation (GO:0050819) | 2.42195429 |
| 172 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.42008583 |
| 173 | alpha-linolenic acid metabolic process (GO:0036109) | 2.41055462 |
| 174 | blood coagulation, intrinsic pathway (GO:0007597) | 2.40827955 |
| 175 | intestinal cholesterol absorption (GO:0030299) | 2.40070704 |
| 176 | proline metabolic process (GO:0006560) | 2.39821735 |
| 177 | regulation of apoptotic cell clearance (GO:2000425) | 2.38335049 |
| 178 | cellular copper ion homeostasis (GO:0006878) | 2.38164244 |
| 179 | positive regulation of nuclease activity (GO:0032075) | 2.34589280 |
| 180 | zinc ion transmembrane transport (GO:0071577) | 2.32931838 |
| 181 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.30531791 |
| 182 | negative regulation of blood coagulation (GO:0030195) | 2.29711347 |
| 183 | negative regulation of hemostasis (GO:1900047) | 2.29711347 |
| 184 | L-ascorbic acid metabolic process (GO:0019852) | 2.29475402 |
| 185 | positive regulation of extracellular matrix organization (GO:1903055) | 2.26143668 |
| 186 | platelet degranulation (GO:0002576) | 2.24606818 |
| 187 | cellular zinc ion homeostasis (GO:0006882) | 2.24493071 |
| 188 | nuclear envelope reassembly (GO:0031468) | 2.24409123 |
| 189 | mitotic nuclear envelope reassembly (GO:0007084) | 2.24409123 |
| 190 | adhesion of symbiont to host (GO:0044406) | 2.24180083 |
| 191 | urea cycle (GO:0000050) | 2.22670166 |
| 192 | cell redox homeostasis (GO:0045454) | 2.22599727 |
| 193 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.22032260 |
| 194 | endodermal cell differentiation (GO:0035987) | 2.21651663 |
| 195 | purine ribonucleotide transport (GO:0015868) | 2.21280528 |
| 196 | GDP-mannose metabolic process (GO:0019673) | 2.20733949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.49879839 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.96881244 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.54788998 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.49863038 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.41623563 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.29076406 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.83751569 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.76302316 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.72555707 |
| 10 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.66770832 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.57107569 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.56233279 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.46946233 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.46919501 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.45457633 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.42770060 |
| 17 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.41219221 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34158958 |
| 19 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.32999523 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.22623618 |
| 21 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.21941857 |
| 22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.21278618 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.20822954 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 2.20239752 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.18022396 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.16758494 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.14917716 |
| 28 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.12750832 |
| 29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.11883577 |
| 30 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.11795231 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.09524682 |
| 32 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.08524770 |
| 33 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.08262688 |
| 34 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.07180659 |
| 35 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.04635630 |
| 36 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.98445572 |
| 37 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.95560130 |
| 38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.94146556 |
| 39 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.89556573 |
| 40 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.89461223 |
| 41 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.88608755 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.87636095 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.82917372 |
| 44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.81578228 |
| 45 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.79680635 |
| 46 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.79370863 |
| 47 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.79264522 |
| 48 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.78820830 |
| 49 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.75644327 |
| 50 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.75333895 |
| 51 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71976822 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.71412558 |
| 53 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.68556941 |
| 54 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.68174999 |
| 55 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.66620665 |
| 56 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.66613137 |
| 57 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.66613137 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.64191568 |
| 59 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.61782408 |
| 60 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60594521 |
| 61 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.59619647 |
| 62 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.57399962 |
| 63 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.55051055 |
| 64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53198223 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.50075383 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49974978 |
| 67 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.49839497 |
| 68 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.49235712 |
| 69 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.48892896 |
| 70 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.48877343 |
| 71 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.48002474 |
| 72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45078714 |
| 73 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.44482583 |
| 74 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.43723646 |
| 75 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.43421029 |
| 76 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.41959867 |
| 77 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.41670106 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39961404 |
| 79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.39412359 |
| 80 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.39412359 |
| 81 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.36752968 |
| 82 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36655988 |
| 83 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.36513010 |
| 84 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.35938733 |
| 85 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.35324839 |
| 86 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.34247877 |
| 87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33206498 |
| 88 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.32166110 |
| 89 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.30924957 |
| 90 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.30030563 |
| 91 | ATF3_27146783_Chip-Seq_COLON_Human | 1.29823999 |
| 92 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29487900 |
| 93 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.28849072 |
| 94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.28469054 |
| 95 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.28454403 |
| 96 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.28387653 |
| 97 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.28303664 |
| 98 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27688954 |
| 99 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27271326 |
| 100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.26886920 |
| 101 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.26742931 |
| 102 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.26557205 |
| 103 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26470333 |
| 104 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26138774 |
| 105 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.24292142 |
| 106 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.23380004 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23097962 |
| 108 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.21359143 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 1.21340970 |
| 110 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20229212 |
| 111 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18594941 |
| 112 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18594941 |
| 113 | CJUN_26792858_Chip-Seq_BT549_Human | 1.18452554 |
| 114 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.18370445 |
| 115 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18077427 |
| 116 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17363358 |
| 117 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.17326004 |
| 118 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16489262 |
| 119 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15844326 |
| 120 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.15652296 |
| 121 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14590259 |
| 122 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14451173 |
| 123 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13973183 |
| 124 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12540418 |
| 125 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.12378121 |
| 126 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.11177441 |
| 127 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.10289685 |
| 128 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10202478 |
| 129 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09339486 |
| 130 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.08385723 |
| 131 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.08236912 |
| 132 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.07732563 |
| 133 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.07721804 |
| 134 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07384529 |
| 135 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06588379 |
| 136 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.06449570 |
| 137 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06266907 |
| 138 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05979338 |
| 139 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.05844422 |
| 140 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.05553553 |
| 141 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04848525 |
| 142 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.04142801 |
| 143 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04002578 |
| 144 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.03569880 |
| 145 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03507115 |
| 146 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.02638692 |
| 147 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02281242 |
| 148 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.01376963 |
| 149 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99988262 |
| 150 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98536571 |
| 151 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97029949 |
| 152 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.96391592 |
| 153 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95814066 |
| 154 | MYB_26560356_Chip-Seq_TH2_Human | 0.95663526 |
| 155 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95499677 |
| 156 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93576042 |
| 157 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.93528479 |
| 158 | VDR_22108803_ChIP-Seq_LS180_Human | 0.92680823 |
| 159 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92506844 |
| 160 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92068665 |
| 161 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91790716 |
| 162 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89465985 |
| 163 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.88680814 |
| 164 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88318449 |
| 165 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88291403 |
| 166 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88235195 |
| 167 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88065872 |
| 168 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87756027 |
| 169 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.87101941 |
| 170 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86735142 |
| 171 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85691564 |
| 172 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.85111691 |
| 173 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85039224 |
| 174 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.84168920 |
| 175 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83973031 |
| 176 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.83930952 |
| 177 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.83097079 |
| 178 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.81964482 |
| 179 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.79959666 |
| 180 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.79423242 |
| 181 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.79134694 |
| 182 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.78919579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 4.54196051 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 4.24507770 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.90570034 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.68508806 |
| 5 | MP0003646_muscle_fatigue | 3.42758221 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.40880717 |
| 7 | MP0004084_abnormal_cardiac_muscle | 3.36983354 |
| 8 | MP0009840_abnormal_foam_cell | 3.27913567 |
| 9 | MP0004272_abnormal_basement_membrane | 3.20733222 |
| 10 | MP0003183_abnormal_peptide_metabolism | 2.82317687 |
| 11 | MP0005257_abnormal_intraocular_pressure | 2.71671093 |
| 12 | MP0004215_abnormal_myocardial_fiber | 2.63741379 |
| 13 | MP0009643_abnormal_urine_homeostasis | 2.50217320 |
| 14 | MP0000751_myopathy | 2.49045154 |
| 15 | MP0001765_abnormal_ion_homeostasis | 2.47861153 |
| 16 | MP0002877_abnormal_melanocyte_morpholog | 2.43150263 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.39952906 |
| 18 | MP0005332_abnormal_amino_acid | 2.30404541 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.28152880 |
| 20 | MP0001958_emphysema | 2.27470609 |
| 21 | MP0005365_abnormal_bile_salt | 2.24985264 |
| 22 | MP0004036_abnormal_muscle_relaxation | 2.22114714 |
| 23 | MP0003195_calcinosis | 2.20123035 |
| 24 | MP0005451_abnormal_body_composition | 2.10059801 |
| 25 | MP0003172_abnormal_lysosome_physiology | 2.08941149 |
| 26 | MP0005360_urolithiasis | 2.08095409 |
| 27 | MP0004484_altered_response_of | 2.06280825 |
| 28 | MP0001756_abnormal_urination | 2.05824617 |
| 29 | MP0002972_abnormal_cardiac_muscle | 2.01280915 |
| 30 | MP0005330_cardiomyopathy | 1.95827471 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 1.95338547 |
| 32 | MP0002136_abnormal_kidney_physiology | 1.93049984 |
| 33 | MP0004019_abnormal_vitamin_homeostasis | 1.89835806 |
| 34 | MP0008775_abnormal_heart_ventricle | 1.84254377 |
| 35 | MP0000343_altered_response_to | 1.83457914 |
| 36 | MP0005636_abnormal_mineral_homeostasis | 1.80641176 |
| 37 | MP0005408_hypopigmentation | 1.80124700 |
| 38 | MP0010234_abnormal_vibrissa_follicle | 1.78798562 |
| 39 | MP0003941_abnormal_skin_development | 1.75032327 |
| 40 | MP0009697_abnormal_copulation | 1.69921402 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.67362161 |
| 42 | MP0003950_abnormal_plasma_membrane | 1.64280912 |
| 43 | MP0004147_increased_porphyrin_level | 1.64068235 |
| 44 | MP0001835_abnormal_antigen_presentation | 1.63683218 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.56805082 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.52768603 |
| 47 | MP0003828_pulmonary_edema | 1.52737041 |
| 48 | MP0003436_decreased_susceptibility_to | 1.51716650 |
| 49 | MP0003878_abnormal_ear_physiology | 1.49347602 |
| 50 | MP0005377_hearing/vestibular/ear_phenot | 1.49347602 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.46533801 |
| 52 | MP0010368_abnormal_lymphatic_system | 1.46521858 |
| 53 | MP0000538_abnormal_urinary_bladder | 1.46171806 |
| 54 | MP0000749_muscle_degeneration | 1.45484470 |
| 55 | MP0002254_reproductive_system_inflammat | 1.45051303 |
| 56 | MP0000230_abnormal_systemic_arterial | 1.44521558 |
| 57 | MP0005165_increased_susceptibility_to | 1.43692834 |
| 58 | MP0001915_intracranial_hemorrhage | 1.42041701 |
| 59 | MP0002148_abnormal_hypersensitivity_rea | 1.41186294 |
| 60 | MP0002419_abnormal_innate_immunity | 1.40629362 |
| 61 | MP0005023_abnormal_wound_healing | 1.39865782 |
| 62 | MP0005085_abnormal_gallbladder_physiolo | 1.39750461 |
| 63 | MP0001544_abnormal_cardiovascular_syste | 1.37689958 |
| 64 | MP0005385_cardiovascular_system_phenoty | 1.37689958 |
| 65 | MP0003724_increased_susceptibility_to | 1.36946179 |
| 66 | MP0008007_abnormal_cellular_replicative | 1.34802283 |
| 67 | MP0004957_abnormal_blastocyst_morpholog | 1.33719656 |
| 68 | MP0006082_CNS_inflammation | 1.33547492 |
| 69 | MP0009785_altered_susceptibility_to | 1.29846927 |
| 70 | MP0008932_abnormal_embryonic_tissue | 1.29748924 |
| 71 | MP0004130_abnormal_muscle_cell | 1.29406314 |
| 72 | MP0005620_abnormal_muscle_contractility | 1.26367824 |
| 73 | MP0010386_abnormal_urinary_bladder | 1.25181019 |
| 74 | MP0003186_abnormal_redox_activity | 1.23914329 |
| 75 | MP0000858_altered_metastatic_potential | 1.21585600 |
| 76 | MP0008004_abnormal_stomach_pH | 1.19214102 |
| 77 | MP0001661_extended_life_span | 1.18762642 |
| 78 | MP0002060_abnormal_skin_morphology | 1.18394485 |
| 79 | MP0003868_abnormal_feces_composition | 1.16864916 |
| 80 | MP0002295_abnormal_pulmonary_circulatio | 1.16671065 |
| 81 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14918912 |
| 82 | MP0009764_decreased_sensitivity_to | 1.14259232 |
| 83 | MP0003111_abnormal_nucleus_morphology | 1.13328305 |
| 84 | MP0002876_abnormal_thyroid_physiology | 1.10925037 |
| 85 | MP0004087_abnormal_muscle_fiber | 1.09202508 |
| 86 | MP0000358_abnormal_cell_content/ | 1.06950848 |
| 87 | MP0009780_abnormal_chondrocyte_physiolo | 1.06618203 |
| 88 | MP0010329_abnormal_lipoprotein_level | 1.05961229 |
| 89 | MP0002090_abnormal_vision | 1.05805424 |
| 90 | MP0003693_abnormal_embryo_hatching | 1.05756427 |
| 91 | MP0001533_abnormal_skeleton_physiology | 1.05545334 |
| 92 | MP0004510_myositis | 1.03799942 |
| 93 | MP0004233_abnormal_muscle_weight | 1.03716074 |
| 94 | MP0005025_abnormal_response_to | 1.03636114 |
| 95 | MP0008469_abnormal_protein_level | 1.02675256 |
| 96 | MP0000750_abnormal_muscle_regeneration | 1.02565781 |
| 97 | MP0003303_peritoneal_inflammation | 1.02333014 |
| 98 | MP0002896_abnormal_bone_mineralization | 1.01975727 |
| 99 | MP0000609_abnormal_liver_physiology | 1.01935977 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 1.01813703 |
| 101 | MP0010630_abnormal_cardiac_muscle | 1.01778230 |
| 102 | MP0003221_abnormal_cardiomyocyte_apopto | 1.01757297 |
| 103 | MP0003075_altered_response_to | 1.01594187 |
| 104 | MP0006138_congestive_heart_failure | 1.01445173 |
| 105 | MP0008260_abnormal_autophagy | 1.00780607 |
| 106 | MP0005000_abnormal_immune_tolerance | 1.00493030 |
| 107 | MP0002998_abnormal_bone_remodeling | 1.00205454 |
| 108 | MP0005623_abnormal_meninges_morphology | 0.99632964 |
| 109 | MP0005535_abnormal_body_temperature | 0.99085683 |
| 110 | MP0005166_decreased_susceptibility_to | 0.97234418 |
| 111 | MP0005310_abnormal_salivary_gland | 0.97089832 |
| 112 | MP0003137_abnormal_impulse_conducting | 0.96998053 |
| 113 | MP0001845_abnormal_inflammatory_respons | 0.96318616 |
| 114 | MP0001243_abnormal_dermal_layer | 0.96313602 |
| 115 | MP0005167_abnormal_blood-brain_barrier | 0.95076648 |
| 116 | MP0001730_embryonic_growth_arrest | 0.94519140 |
| 117 | MP0003866_abnormal_defecation | 0.94304765 |
| 118 | MP0008875_abnormal_xenobiotic_pharmacok | 0.94132617 |
| 119 | MP0005197_abnormal_uvea_morphology | 0.92722494 |
| 120 | MP0004085_abnormal_heartbeat | 0.92444999 |
| 121 | MP0005084_abnormal_gallbladder_morpholo | 0.90040205 |
| 122 | MP0000747_muscle_weakness | 0.89703096 |
| 123 | MP0002909_abnormal_adrenal_gland | 0.88691041 |
| 124 | MP0001542_abnormal_bone_strength | 0.88668849 |
| 125 | MP0001853_heart_inflammation | 0.88251146 |
| 126 | MP0001849_ear_inflammation | 0.87204339 |
| 127 | MP0001663_abnormal_digestive_system | 0.86047557 |
| 128 | MP0003566_abnormal_cell_adhesion | 0.84956836 |
| 129 | MP0001666_abnormal_nutrient_absorption | 0.84796082 |
| 130 | MP0006054_spinal_hemorrhage | 0.84234752 |
| 131 | MP0009384_cardiac_valve_regurgitation | 0.84027221 |
| 132 | MP0003091_abnormal_cell_migration | 0.82527073 |
| 133 | MP0003453_abnormal_keratinocyte_physiol | 0.82524260 |
| 134 | MP0010094_abnormal_chromosome_stability | 0.81910143 |
| 135 | MP0005464_abnormal_platelet_physiology | 0.81091028 |
| 136 | MP0002332_abnormal_exercise_endurance | 0.80783956 |
| 137 | MP0005164_abnormal_response_to | 0.80732449 |
| 138 | MP0010030_abnormal_orbit_morphology | 0.79659290 |
| 139 | MP0001790_abnormal_immune_system | 0.79014040 |
| 140 | MP0005387_immune_system_phenotype | 0.79014040 |
| 141 | MP0010307_abnormal_tumor_latency | 0.77133020 |
| 142 | MP0003795_abnormal_bone_structure | 0.76633131 |
| 143 | MP0004264_abnormal_extraembryonic_tissu | 0.76554007 |
| 144 | MP0000598_abnormal_liver_morphology | 0.76547660 |
| 145 | MP0001764_abnormal_homeostasis | 0.76179613 |
| 146 | MP0000767_abnormal_smooth_muscle | 0.75609001 |
| 147 | MP0003656_abnormal_erythrocyte_physiolo | 0.75414014 |
| 148 | MP0003638_abnormal_response/metabolism_ | 0.74818705 |
| 149 | MP0004782_abnormal_surfactant_physiolog | 0.74812238 |
| 150 | MP0000604_amyloidosis | 0.74652512 |
| 151 | MP0003279_aneurysm | 0.73967265 |
| 152 | MP0004858_abnormal_nervous_system | 0.73668018 |
| 153 | MP0000003_abnormal_adipose_tissue | 0.73042475 |
| 154 | MP0001664_abnormal_digestion | 0.72566271 |
| 155 | MP0002452_abnormal_antigen_presenting | 0.72482019 |
| 156 | MP0002933_joint_inflammation | 0.72223961 |
| 157 | MP0002135_abnormal_kidney_morphology | 0.71790767 |
| 158 | MP0002106_abnormal_muscle_physiology | 0.70889998 |
| 159 | MP0003718_maternal_effect | 0.69763430 |
| 160 | MP0002089_abnormal_postnatal_growth/wei | 0.69274209 |
| 161 | MP0003045_fibrosis | 0.69033869 |
| 162 | MP0000371_diluted_coat_color | 0.68900316 |
| 163 | MP0002938_white_spotting | 0.67476554 |
| 164 | MP0005501_abnormal_skin_physiology | 0.66911839 |
| 165 | MP0003984_embryonic_growth_retardation | 0.66386182 |
| 166 | MP0003077_abnormal_cell_cycle | 0.66234367 |
| 167 | MP0001881_abnormal_mammary_gland | 0.65355990 |
| 168 | MP0001672_abnormal_embryogenesis/_devel | 0.65289265 |
| 169 | MP0005380_embryogenesis_phenotype | 0.65289265 |
| 170 | MP0005384_cellular_phenotype | 0.64897714 |
| 171 | MP0001697_abnormal_embryo_size | 0.64852814 |
| 172 | MP0002080_prenatal_lethality | 0.64815718 |
| 173 | MP0005275_abnormal_skin_tensile | 0.63741638 |
| 174 | MP0005508_abnormal_skeleton_morphology | 0.63413034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 4.96589385 |
| 2 | Hyperactive renin-angiotensin system (HP:0000841) | 4.81677592 |
| 3 | Increased circulating renin level (HP:0000848) | 4.57552930 |
| 4 | Metabolic alkalosis (HP:0200114) | 4.44324240 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 4.38139475 |
| 6 | Hypokalemic alkalosis (HP:0001949) | 4.36678415 |
| 7 | Abnormality of chloride homeostasis (HP:0011422) | 4.33743040 |
| 8 | Hypomagnesemia (HP:0002917) | 4.29404275 |
| 9 | Vertebral compression fractures (HP:0002953) | 4.11277298 |
| 10 | Gout (HP:0001997) | 4.10512407 |
| 11 | Polyuria (HP:0000103) | 4.09566871 |
| 12 | Proximal tubulopathy (HP:0000114) | 4.00565863 |
| 13 | Abnormal urine output (HP:0012590) | 3.93275000 |
| 14 | Abnormality of renal excretion (HP:0011036) | 3.88689304 |
| 15 | Abnormality of magnesium homeostasis (HP:0004921) | 3.87466228 |
| 16 | Protrusio acetabuli (HP:0003179) | 3.85089891 |
| 17 | Deep venous thrombosis (HP:0002625) | 3.80508866 |
| 18 | Generalized aminoaciduria (HP:0002909) | 3.55339689 |
| 19 | Dysostosis multiplex (HP:0000943) | 3.54602914 |
| 20 | Abnormal drinking behavior (HP:0030082) | 3.45133442 |
| 21 | Polydipsia (HP:0001959) | 3.45133442 |
| 22 | Tetany (HP:0001281) | 3.37921675 |
| 23 | Hyperaldosteronism (HP:0000859) | 3.37326086 |
| 24 | Abnormality of renin-angiotensin system (HP:0000847) | 3.36725670 |
| 25 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.34782086 |
| 26 | Ketoacidosis (HP:0001993) | 3.33483798 |
| 27 | Mucopolysacchariduria (HP:0008155) | 3.20770518 |
| 28 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.20770518 |
| 29 | Sudden death (HP:0001699) | 3.11110864 |
| 30 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.98321506 |
| 31 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.98321506 |
| 32 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.98321506 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.96727563 |
| 34 | Ventricular tachycardia (HP:0004756) | 2.94646977 |
| 35 | Increased cerebral lipofuscin (HP:0011813) | 2.93534082 |
| 36 | Increased purine levels (HP:0004368) | 2.93223874 |
| 37 | Hyperuricemia (HP:0002149) | 2.93223874 |
| 38 | Cardiovascular calcification (HP:0011915) | 2.91375104 |
| 39 | Renal salt wasting (HP:0000127) | 2.89581774 |
| 40 | Increased serum pyruvate (HP:0003542) | 2.89455539 |
| 41 | Systemic lupus erythematosus (HP:0002725) | 2.88205463 |
| 42 | Palpitations (HP:0001962) | 2.88107067 |
| 43 | Glycosuria (HP:0003076) | 2.87605922 |
| 44 | Abnormality of urine glucose concentration (HP:0011016) | 2.87605922 |
| 45 | Abnormality of glycolysis (HP:0004366) | 2.86562616 |
| 46 | Myocardial infarction (HP:0001658) | 2.86391424 |
| 47 | Vascular calcification (HP:0004934) | 2.84162437 |
| 48 | Hypobetalipoproteinemia (HP:0003563) | 2.82613593 |
| 49 | Xanthomatosis (HP:0000991) | 2.78337159 |
| 50 | Asymmetric septal hypertrophy (HP:0001670) | 2.75221910 |
| 51 | Intrahepatic cholestasis (HP:0001406) | 2.73685445 |
| 52 | Abnormality of glycolipid metabolism (HP:0010969) | 2.71203479 |
| 53 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.71203479 |
| 54 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.71203479 |
| 55 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.70349394 |
| 56 | Cervical subluxation (HP:0003308) | 2.66594085 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.66451526 |
| 58 | Orthostatic hypotension (HP:0001278) | 2.63749783 |
| 59 | Hepatic necrosis (HP:0002605) | 2.63677737 |
| 60 | Mitral stenosis (HP:0001718) | 2.62946047 |
| 61 | Abnormality of macrophages (HP:0004311) | 2.61882385 |
| 62 | Atrial fibrillation (HP:0005110) | 2.58945395 |
| 63 | Right ventricular cardiomyopathy (HP:0011663) | 2.56722333 |
| 64 | Exercise-induced muscle cramps (HP:0003710) | 2.56596460 |
| 65 | Axonal loss (HP:0003447) | 2.53957683 |
| 66 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.53781465 |
| 67 | Prolonged partial thromboplastin time (HP:0003645) | 2.51785417 |
| 68 | Abnormality of the common coagulation pathway (HP:0010990) | 2.50624897 |
| 69 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.50213854 |
| 70 | Hyperglycinuria (HP:0003108) | 2.48845433 |
| 71 | Syncope (HP:0001279) | 2.47821694 |
| 72 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.47318998 |
| 73 | Hypercalciuria (HP:0002150) | 2.46035213 |
| 74 | Complement deficiency (HP:0004431) | 2.45577465 |
| 75 | Recurrent abscess formation (HP:0002722) | 2.44917275 |
| 76 | Hypolipoproteinemia (HP:0010981) | 2.44417351 |
| 77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.44401537 |
| 78 | Dicarboxylic aciduria (HP:0003215) | 2.44401537 |
| 79 | Hypokalemia (HP:0002900) | 2.43975381 |
| 80 | Metaphyseal cupping (HP:0003021) | 2.41948961 |
| 81 | Cholecystitis (HP:0001082) | 2.41589042 |
| 82 | Abnormal gallbladder physiology (HP:0012438) | 2.41589042 |
| 83 | Osteolytic defects of the hand bones (HP:0009699) | 2.41193383 |
| 84 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.41193383 |
| 85 | Primary atrial arrhythmia (HP:0001692) | 2.40798247 |
| 86 | Nuclear cataract (HP:0100018) | 2.40559879 |
| 87 | Abnormality of complement system (HP:0005339) | 2.39811341 |
| 88 | Alkalosis (HP:0001948) | 2.39192399 |
| 89 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.39178385 |
| 90 | J-shaped sella turcica (HP:0002680) | 2.38680171 |
| 91 | Muscle fiber splitting (HP:0003555) | 2.35393199 |
| 92 | Hydroxyprolinuria (HP:0003080) | 2.34798527 |
| 93 | Abnormality of proline metabolism (HP:0010907) | 2.34798527 |
| 94 | Nausea (HP:0002018) | 2.34342811 |
| 95 | Supraventricular tachycardia (HP:0004755) | 2.32707489 |
| 96 | Neoplasm of head and neck (HP:0012288) | 2.30791646 |
| 97 | Esophageal neoplasm (HP:0100751) | 2.30791646 |
| 98 | Prolonged neonatal jaundice (HP:0006579) | 2.30731270 |
| 99 | Ankle contracture (HP:0006466) | 2.29384159 |
| 100 | Abnormality of the Achilles tendon (HP:0005109) | 2.29297215 |
| 101 | Hepatocellular necrosis (HP:0001404) | 2.28478403 |
| 102 | Abnormal delivery (HP:0001787) | 2.27940817 |
| 103 | Acute encephalopathy (HP:0006846) | 2.27675820 |
| 104 | Short nail (HP:0001799) | 2.26454369 |
| 105 | Abnormality of the acetabulum (HP:0003170) | 2.26266599 |
| 106 | Supraventricular arrhythmia (HP:0005115) | 2.25681772 |
| 107 | Glomerulonephritis (HP:0000099) | 2.22644742 |
| 108 | Hyperphosphaturia (HP:0003109) | 2.21055434 |
| 109 | Mitochondrial inheritance (HP:0001427) | 2.20913412 |
| 110 | Acute necrotizing encephalopathy (HP:0006965) | 2.20566240 |
| 111 | Lipoatrophy (HP:0100578) | 2.20281954 |
| 112 | Progressive neurologic deterioration (HP:0002344) | 2.19709348 |
| 113 | Ketosis (HP:0001946) | 2.19177691 |
| 114 | Eczematoid dermatitis (HP:0000976) | 2.18863966 |
| 115 | Loss of speech (HP:0002371) | 2.18500590 |
| 116 | Abnormality of dentin (HP:0010299) | 2.16907788 |
| 117 | Calf muscle hypertrophy (HP:0008981) | 2.16338356 |
| 118 | Nonimmune hydrops fetalis (HP:0001790) | 2.15792973 |
| 119 | Myoglobinuria (HP:0002913) | 2.15124599 |
| 120 | Abnormality of carpal bone ossification (HP:0006257) | 2.13716179 |
| 121 | Flat acetabular roof (HP:0003180) | 2.13484249 |
| 122 | Renal tubular acidosis (HP:0001947) | 2.13478849 |
| 123 | Abnormality of the umbilical cord (HP:0010881) | 2.13382152 |
| 124 | Type I transferrin isoform profile (HP:0003642) | 2.10980459 |
| 125 | Ovoid vertebral bodies (HP:0003300) | 2.09768788 |
| 126 | Abnormality of the calf musculature (HP:0001430) | 2.08969080 |
| 127 | Abnormal urine phosphate concentration (HP:0012599) | 2.08012499 |
| 128 | Skin nodule (HP:0200036) | 2.07994500 |
| 129 | Reduced antithrombin III activity (HP:0001976) | 2.06221816 |
| 130 | Hypoalphalipoproteinemia (HP:0003233) | 2.05331313 |
| 131 | Hypercholesterolemia (HP:0003124) | 2.05147467 |
| 132 | Dilated cardiomyopathy (HP:0001644) | 2.04812064 |
| 133 | Achilles tendon contracture (HP:0001771) | 2.04465442 |
| 134 | Abnormality of the intrinsic pathway (HP:0010989) | 2.03225381 |
| 135 | Pheochromocytoma (HP:0002666) | 2.01794291 |
| 136 | Wormian bones (HP:0002645) | 2.01375298 |
| 137 | Increased muscle lipid content (HP:0009058) | 2.00440903 |
| 138 | Vomiting (HP:0002013) | 2.00146730 |
| 139 | Neuroendocrine neoplasm (HP:0100634) | 2.00050821 |
| 140 | Increased CSF lactate (HP:0002490) | 1.99727975 |
| 141 | Methylmalonic aciduria (HP:0012120) | 1.99557191 |
| 142 | Interstitial pulmonary disease (HP:0006530) | 1.99019493 |
| 143 | Conjunctival hamartoma (HP:0100780) | 1.98577743 |
| 144 | Conjugated hyperbilirubinemia (HP:0002908) | 1.97945140 |
| 145 | Beaking of vertebral bodies (HP:0004568) | 1.97192465 |
| 146 | Respiratory failure (HP:0002878) | 1.97040281 |
| 147 | Hypokinesia (HP:0002375) | 1.96521267 |
| 148 | Decreased circulating renin level (HP:0003351) | 1.96378490 |
| 149 | Tetraparesis (HP:0002273) | 1.95039370 |
| 150 | Abnormality of potassium homeostasis (HP:0011042) | 1.94907427 |
| 151 | Distal lower limb muscle weakness (HP:0009053) | 1.94424000 |
| 152 | Metabolic acidosis (HP:0001942) | 1.93918504 |
| 153 | Abnormality of renal resorption (HP:0011038) | 1.93857475 |
| 154 | Soft skin (HP:0000977) | 1.90836520 |
| 155 | Blue sclerae (HP:0000592) | 1.90607761 |
| 156 | Elbow flexion contracture (HP:0002987) | 1.89984316 |
| 157 | Joint hemorrhage (HP:0005261) | 1.89233457 |
| 158 | Amyloidosis (HP:0011034) | 1.88603528 |
| 159 | Hypoglycemic coma (HP:0001325) | 1.88146938 |
| 160 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.87715170 |
| 161 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.87715170 |
| 162 | Single umbilical artery (HP:0001195) | 1.87715170 |
| 163 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.87686566 |
| 164 | Fat malabsorption (HP:0002630) | 1.85903214 |
| 165 | Back pain (HP:0003418) | 1.84371917 |
| 166 | Hyperammonemia (HP:0001987) | 1.81590789 |
| 167 | Cerebral aneurysm (HP:0004944) | 1.75261999 |
| 168 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.74698595 |
| 169 | Aortic dissection (HP:0002647) | 1.74185866 |
| 170 | Generalized amyotrophy (HP:0003700) | 1.73644776 |
| 171 | Purpura (HP:0000979) | 1.72978873 |
| 172 | Abnormal protein glycosylation (HP:0012346) | 1.71110902 |
| 173 | Abnormal glycosylation (HP:0012345) | 1.71110902 |
| 174 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.71110902 |
| 175 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.71110902 |
| 176 | Entropion (HP:0000621) | 1.70487615 |
| 177 | Upper limb amyotrophy (HP:0009129) | 1.69065489 |
| 178 | Distal upper limb amyotrophy (HP:0007149) | 1.69065489 |
| 179 | Cardiomegaly (HP:0001640) | 1.68571031 |
| 180 | Microglossia (HP:0000171) | 1.67530955 |
| 181 | Spinal rigidity (HP:0003306) | 1.66619067 |
| 182 | Abnormal ossification of hand bones (HP:0005921) | 1.66432484 |
| 183 | Rough bone trabeculation (HP:0100670) | 1.65724108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 5.22881345 |
| 2 | WNK3 | 3.95278015 |
| 3 | OXSR1 | 3.66489825 |
| 4 | MYLK | 2.97969164 |
| 5 | TESK1 | 2.85818149 |
| 6 | LMTK2 | 2.73495368 |
| 7 | EIF2AK1 | 2.59046797 |
| 8 | LIMK1 | 2.52024789 |
| 9 | PBK | 2.45896419 |
| 10 | MST4 | 2.44641950 |
| 11 | EPHA2 | 2.43352900 |
| 12 | PDK4 | 2.35304261 |
| 13 | PDK3 | 2.35304261 |
| 14 | TTN | 2.30865643 |
| 15 | BUB1 | 2.28450370 |
| 16 | PDK2 | 2.22721633 |
| 17 | GRK7 | 2.22459493 |
| 18 | BCKDK | 2.13840312 |
| 19 | STK39 | 2.09074066 |
| 20 | TGFBR2 | 1.94851639 |
| 21 | TESK2 | 1.77232256 |
| 22 | MAP3K12 | 1.74875095 |
| 23 | MAP3K3 | 1.67978971 |
| 24 | STK24 | 1.63624362 |
| 25 | NEK1 | 1.63481382 |
| 26 | TIE1 | 1.58787430 |
| 27 | ERBB4 | 1.57113841 |
| 28 | LATS2 | 1.54850870 |
| 29 | ERN1 | 1.52815940 |
| 30 | IRAK3 | 1.51042810 |
| 31 | KIT | 1.50121206 |
| 32 | EIF2AK3 | 1.49206534 |
| 33 | MET | 1.47594712 |
| 34 | PDGFRA | 1.47503816 |
| 35 | TTK | 1.44383929 |
| 36 | PKN2 | 1.43938995 |
| 37 | PTK2 | 1.40675108 |
| 38 | PHKG1 | 1.38556971 |
| 39 | PHKG2 | 1.38556971 |
| 40 | TBK1 | 1.33030311 |
| 41 | RIPK4 | 1.29790027 |
| 42 | NME2 | 1.29342357 |
| 43 | DDR2 | 1.29246186 |
| 44 | VRK2 | 1.29100927 |
| 45 | NEK9 | 1.28317581 |
| 46 | TRPM7 | 1.24099871 |
| 47 | SRPK1 | 1.23851625 |
| 48 | FRK | 1.23396358 |
| 49 | ICK | 1.18040653 |
| 50 | KDR | 1.16667015 |
| 51 | FGFR4 | 1.16451885 |
| 52 | MAP3K14 | 1.14272993 |
| 53 | IRAK4 | 1.14180687 |
| 54 | TYK2 | 1.10161973 |
| 55 | STK16 | 1.10054494 |
| 56 | WNK1 | 1.09959107 |
| 57 | BLK | 1.09134185 |
| 58 | LATS1 | 1.06662719 |
| 59 | MST1R | 1.03630851 |
| 60 | MAPKAPK3 | 1.00545711 |
| 61 | PIM2 | 1.00312782 |
| 62 | RIPK1 | 0.98315127 |
| 63 | MAP4K1 | 0.98007243 |
| 64 | ARAF | 0.96829709 |
| 65 | TAOK2 | 0.96461064 |
| 66 | MAP3K8 | 0.96050258 |
| 67 | SMG1 | 0.95119034 |
| 68 | CAMKK2 | 0.93735048 |
| 69 | MOS | 0.93264486 |
| 70 | LRRK2 | 0.93043805 |
| 71 | TRIB3 | 0.90225153 |
| 72 | MATK | 0.90024408 |
| 73 | STK38L | 0.88419791 |
| 74 | EPHB1 | 0.88178623 |
| 75 | SGK3 | 0.87386739 |
| 76 | TAOK3 | 0.85870316 |
| 77 | FLT3 | 0.85145219 |
| 78 | SGK2 | 0.84486673 |
| 79 | PLK3 | 0.83659842 |
| 80 | PAK2 | 0.83595735 |
| 81 | MAP2K3 | 0.83582703 |
| 82 | ZAP70 | 0.81678139 |
| 83 | SGK223 | 0.81666344 |
| 84 | SGK494 | 0.81666344 |
| 85 | JAK1 | 0.80024993 |
| 86 | TEC | 0.78595367 |
| 87 | BRSK1 | 0.78038817 |
| 88 | DMPK | 0.77139544 |
| 89 | PRKG2 | 0.76038915 |
| 90 | ILK | 0.74279454 |
| 91 | CSNK1G3 | 0.74267930 |
| 92 | CDK8 | 0.74229958 |
| 93 | CAMK2D | 0.72567866 |
| 94 | PIK3CA | 0.71566155 |
| 95 | CDK6 | 0.69761013 |
| 96 | CDK7 | 0.69269167 |
| 97 | PINK1 | 0.66660329 |
| 98 | STK3 | 0.66392454 |
| 99 | BMX | 0.65892597 |
| 100 | CLK1 | 0.64542881 |
| 101 | BTK | 0.64167897 |
| 102 | BRSK2 | 0.63900933 |
| 103 | STK4 | 0.63882807 |
| 104 | SCYL2 | 0.63489990 |
| 105 | RPS6KC1 | 0.63344663 |
| 106 | RPS6KL1 | 0.63344663 |
| 107 | RPS6KA6 | 0.62577790 |
| 108 | PRKCD | 0.61596524 |
| 109 | CSNK1A1L | 0.60769948 |
| 110 | SYK | 0.60272006 |
| 111 | CSF1R | 0.60191264 |
| 112 | TSSK6 | 0.59851837 |
| 113 | PLK1 | 0.59807949 |
| 114 | AURKB | 0.58529792 |
| 115 | NTRK1 | 0.57418629 |
| 116 | PRKCE | 0.57345434 |
| 117 | PAK4 | 0.56475149 |
| 118 | OBSCN | 0.55782063 |
| 119 | CSNK1G1 | 0.55042226 |
| 120 | PAK1 | 0.54313634 |
| 121 | PDPK1 | 0.53981695 |
| 122 | STK38 | 0.53882351 |
| 123 | GRK6 | 0.53563262 |
| 124 | RPS6KA2 | 0.52206712 |
| 125 | PAK3 | 0.50312991 |
| 126 | WEE1 | 0.49283178 |
| 127 | MAPK12 | 0.48847110 |
| 128 | PTK6 | 0.48737271 |
| 129 | CHEK2 | 0.47748350 |
| 130 | FES | 0.47173602 |
| 131 | STK10 | 0.47084698 |
| 132 | INSRR | 0.46417707 |
| 133 | PDK1 | 0.46158582 |
| 134 | TXK | 0.45068255 |
| 135 | DAPK3 | 0.44734899 |
| 136 | FER | 0.43563981 |
| 137 | AKT2 | 0.43111241 |
| 138 | DAPK1 | 0.42855548 |
| 139 | GRK5 | 0.42801426 |
| 140 | NEK2 | 0.42771941 |
| 141 | PRKD1 | 0.42721164 |
| 142 | PIK3CG | 0.42464594 |
| 143 | SIK1 | 0.41921421 |
| 144 | MAP3K5 | 0.41735362 |
| 145 | JAK2 | 0.41587823 |
| 146 | AURKA | 0.41484583 |
| 147 | RPS6KB2 | 0.41319794 |
| 148 | PTK2B | 0.41176418 |
| 149 | ERBB3 | 0.40184232 |
| 150 | EPHB2 | 0.40032851 |
| 151 | MAPKAPK5 | 0.39302840 |
| 152 | FGFR1 | 0.39187222 |
| 153 | ITK | 0.38683501 |
| 154 | CDC7 | 0.38672505 |
| 155 | MAP3K1 | 0.37827492 |
| 156 | ABL2 | 0.37540379 |
| 157 | ROCK1 | 0.36659508 |
| 158 | GSK3A | 0.35936323 |
| 159 | MAP3K2 | 0.35483621 |
| 160 | EEF2K | 0.34908967 |
| 161 | CAMK4 | 0.34029517 |
| 162 | CSNK2A1 | 0.33993282 |
| 163 | LYN | 0.33577432 |
| 164 | MUSK | 0.33346746 |
| 165 | CDK14 | 0.33164152 |
| 166 | CDK18 | 0.33145133 |
| 167 | MAP3K11 | 0.32929017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.70018556 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.04723400 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.01100951 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.90943871 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.63531946 |
| 6 | * Other glycan degradation_Homo sapiens_hsa00511 | 2.49556913 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 2.47861178 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.46499198 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.38245785 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.30090014 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.22158574 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.10369818 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.06286402 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.92707279 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.87231973 |
| 16 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.83631185 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.75760371 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.74618881 |
| 19 | Carbon metabolism_Homo sapiens_hsa01200 | 1.69375335 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.67485039 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.67346888 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.67298639 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.66008874 |
| 24 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.64355312 |
| 25 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.63172090 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.60325734 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57271161 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.55650510 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.53841330 |
| 30 | Mineral absorption_Homo sapiens_hsa04978 | 1.49757963 |
| 31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.48308527 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.42281357 |
| 33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.41589695 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.39729846 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.35335636 |
| 36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.34344867 |
| 37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.34018125 |
| 38 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.31784272 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31368124 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.30548790 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.30365194 |
| 42 | DNA replication_Homo sapiens_hsa03030 | 1.29082524 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23842533 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20648836 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.19306044 |
| 46 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.18302294 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17969265 |
| 48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.15727592 |
| 49 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13794379 |
| 50 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.11832751 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11806659 |
| 52 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.11330825 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.10943009 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.10669312 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.09704425 |
| 56 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.08340452 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.06901166 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.06232883 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.05614345 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.05289870 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 1.04999311 |
| 62 | Galactose metabolism_Homo sapiens_hsa00052 | 1.02485496 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.00766721 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.99819198 |
| 65 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99371134 |
| 66 | Leishmaniasis_Homo sapiens_hsa05140 | 0.96615043 |
| 67 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.95828626 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.94028103 |
| 69 | Mismatch repair_Homo sapiens_hsa03430 | 0.92366903 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 0.92304359 |
| 71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.91411272 |
| 72 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.91231474 |
| 73 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.88349106 |
| 74 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.87080679 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.86394954 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.86383499 |
| 77 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84953245 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.84134609 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.82028689 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80355703 |
| 81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79780073 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.79669752 |
| 83 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.78751464 |
| 84 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74794383 |
| 85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74702937 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.74347198 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73084862 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70416316 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69984567 |
| 90 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.69623666 |
| 91 | Base excision repair_Homo sapiens_hsa03410 | 0.68719899 |
| 92 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.68482396 |
| 93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.67225936 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.66197106 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.65216841 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.62350078 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61303048 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60588287 |
| 99 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.60139270 |
| 100 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.59885711 |
| 101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.59485482 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57901329 |
| 103 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.57132775 |
| 104 | Salmonella infection_Homo sapiens_hsa05132 | 0.56999857 |
| 105 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.55163259 |
| 106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53446767 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.53074926 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53053814 |
| 109 | Shigellosis_Homo sapiens_hsa05131 | 0.52857985 |
| 110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52167859 |
| 111 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.52160158 |
| 112 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52055558 |
| 113 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51645423 |
| 114 | RNA transport_Homo sapiens_hsa03013 | 0.50406034 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49269622 |
| 116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.48794523 |
| 117 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47896483 |
| 118 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47519707 |
| 119 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46460323 |
| 120 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.46126554 |
| 121 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45755801 |
| 122 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.44584527 |
| 123 | Bile secretion_Homo sapiens_hsa04976 | 0.43765008 |
| 124 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42893257 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41768838 |
| 126 | Protein export_Homo sapiens_hsa03060 | 0.40535407 |
| 127 | Cell cycle_Homo sapiens_hsa04110 | 0.40056578 |
| 128 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39390795 |
| 129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38844566 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37067066 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36309143 |
| 132 | Focal adhesion_Homo sapiens_hsa04510 | 0.35641443 |
| 133 | Malaria_Homo sapiens_hsa05144 | 0.35207580 |
| 134 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.34951142 |
| 135 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34289155 |
| 136 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34058293 |
| 137 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33535078 |
| 138 | Histidine metabolism_Homo sapiens_hsa00340 | 0.32913144 |
| 139 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.31497363 |
| 140 | Spliceosome_Homo sapiens_hsa03040 | 0.31075511 |
| 141 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.29705452 |
| 142 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.29446458 |
| 143 | Insulin resistance_Homo sapiens_hsa04931 | 0.28231537 |
| 144 | Amoebiasis_Homo sapiens_hsa05146 | 0.27734422 |
| 145 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.25508661 |
| 146 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.24873828 |
| 147 | Renin secretion_Homo sapiens_hsa04924 | 0.23348210 |
| 148 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.22171890 |
| 149 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22070837 |
| 150 | Lysine degradation_Homo sapiens_hsa00310 | 0.21608472 |

